NASDAQ$KRRO

Korro Bio Inc · Q2 2025 earnings

Q2 2025 earnings · · Before market open · Investor relations

Reports in 4 weeks

Korro Bio hasn't published Q2 2025 actuals yet. The tiles below frame what to compare against; sections further down are historical context only.

  • Most recent report

    Q1 2026

    Revenue
    $0.00
    EPS
    -$1.69
  • Year-ago · Q2 2024

    Q2 2024

    Revenue
    $0.00
    EPS
    -$2.43
  • FY2025 consensus

    Analyst consensus

    Revenue
    $0.00
    EPS
    -$9.74

Revenue & EPS history

Korro Bio · Revenue · Quarterly

$0

Q1 2026-100%vs Q1 2025
Beat estimate in 2 of 3 quarters(67%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports

Historical avg

-4.6%

Avg return

Earnings day

+4.3%

Avg return

5 days after

+1.9%

Avg return

30 days after

43%

10 / 23 earnings

Positive

+20.6%

Q4 2023

Best reaction

-79.3%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-4.3%-16.3%-20.5%
Q4 2025-0.4%+14.5%+20.4%
Q3 2025-79.3%-80.2%-73.8%
Q1 2025+4.1%-2.0%-11.8%
Q4 2024-5.3%-5.7%-1.6%
Q3 2024-25.2%-35.3%-40.2%
Q2 2024+10.4%+22.1%+12.4%
Q1 2024+5.0%+8.8%-15.4%
Q4 2023+20.6%+22.6%-20.3%
Q3 2023+9.4%+192.6%+246.3%
Q2 2023-4.1%-1.4%-39.0%
Q1 2023-5.6%+6.2%+1.9%
Q4 2022+3.1%-2.4%-24.2%
Q3 2022-5.8%+4.4%-11.1%
Q2 2022-11.1%-10.7%-4.9%
Q1 2022+4.0%+1.6%-8.0%
Q3 2021+3.2%-3.5%-17.0%
Q2 2021+0.5%-9.9%-12.3%
Q1 2021-20.3%-14.6%-4.6%
Q3 2020-6.4%+4.6%+59.7%
Q2 2020-1.7%-4.2%-19.8%
Q1 2020-1.1%+5.1%+16.0%
Q3 2019+4.8%+3.6%+11.4%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro